Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States.
Mohamed I ElsaidYou LiCarolyn CatalanoCarlos D MinacapelliKapil GuptaVinod K RustgiPublished in: PharmacoEconomics - open (2020)
Porphyria is associated with significant healthcare costs and utilization burdens driven by increased inpatient admissions, outpatient visits, and pharmaceutical claims.
Keyphrases